Skip to main content
Fig. 5 | BMC Cancer

Fig. 5

From: Computational analysis for identification of early diagnostic biomarkers and prognostic biomarkers of liver cancer based on GEO and TCGA databases and studies on pathways and biological functions affecting the survival time of liver cancer

Fig. 5

Expression levels of 22 Hub Gene. A. genes that is highly expressed in liver cancer. (a) SPP1, (b) AURKA, (c) NQO1, (d) NUSAP1, (e) TOP2A, (f) UBE2C, (g) AFP, (h) GMNN, (i) PTTG1, (j) RRM2, (k) UBE2T, (l) GPC3, (m) SPARCL1 in Normal Liver versus Liver Cancer tissues. B. genes that is lowly expressed in liver cancer. (n) ESR1, (o) CXCL12, (p) FOS, (q) DCN, (r) EGR1, (s) SOCS3, (t) CYP1A2, (u) FOSB, (v) PCK1 in Normal Liver versus Liver Cancer tissues

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us